These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22483298)

  • 21. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications.
    Weickert TW; Goldberg TE; Mishara A; Apud JA; Kolachana BS; Egan MF; Weinberger DR
    Biol Psychiatry; 2004 Nov; 56(9):677-82. PubMed ID: 15522252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond.
    Tunbridge EM; Harrison PJ; Weinberger DR
    Biol Psychiatry; 2006 Jul; 60(2):141-51. PubMed ID: 16476412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions.
    Lewandowski KE
    Harv Rev Psychiatry; 2007; 15(5):233-44. PubMed ID: 17924258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolcapone, COMT polymorphisms and pharmacogenomic treatment of schizophrenia.
    Bitsios P; Roussos P
    Pharmacogenomics; 2011 Apr; 12(4):559-66. PubMed ID: 21521027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of catechol-O-methyltransferase (COMT)-dependent processes in Parkinson's disease and L-DOPA treatment.
    Espinoza S; Manago F; Leo D; Sotnikova TD; Gainetdinov RR
    CNS Neurol Disord Drug Targets; 2012 May; 11(3):251-63. PubMed ID: 22483291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular modeling and metabolic studies of the interaction of catechol-O-methyltransferase and a new nitrocatechol inhibitor.
    Palma PN; Bonifácio MJ; Loureiro AI; Wright LC; Learmonth DA; Soares-da-Silva P
    Drug Metab Dispos; 2003 Mar; 31(3):250-8. PubMed ID: 12584150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and optimization of N-heterocyclic pyridinones as catechol-O-methyltransferase (COMT) inhibitors.
    Zhao Z; Harrison ST; Schubert JW; Sanders JM; Polsky-Fisher S; Zhang NR; McLoughlin D; Gibson CR; Robinson RG; Sachs NA; Kandebo M; Yao L; Smith SM; Hutson PH; Wolkenberg SE; Barrow JC
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2952-2956. PubMed ID: 27133481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The catechol O-methyltransferase Val158Met polymorphism is not associated with broad-based cognitive functioning in schizophrenia.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Sullens A; Yolken RH
    Schizophr Res; 2007 Nov; 96(1-3):87-92. PubMed ID: 17601704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The catechol-O-methyl-transferase gene in tardive dyskinesia.
    Zai CC; Tiwari AK; Müller DJ; De Luca V; Shinkai T; Shaikh S; Ni X; Sibony D; Voineskos AN; Meltzer HY; Lieberman JA; Potkin SG; Remington G; Kennedy JL
    World J Biol Psychiatry; 2010 Sep; 11(6):803-12. PubMed ID: 20586531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain catechol-O-methyltransferase (COMT) inhibition by tolcapone counteracts recognition memory deficits in normal and chronic phencyclidine-treated rats and in COMT-Val transgenic mice.
    Detrait ER; Carr GV; Weinberger DR; Lamberty Y
    Behav Pharmacol; 2016 Aug; 27(5):415-21. PubMed ID: 26919286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors affecting cognitive remediation response in schizophrenia: the role of COMT gene and antipsychotic treatment.
    Bosia M; Zanoletti A; Spangaro M; Buonocore M; Bechi M; Cocchi F; Pirovano A; Lorenzi C; Bramanti P; Smeraldi E; Cavallaro R
    Psychiatry Res; 2014 Jun; 217(1-2):9-14. PubMed ID: 24656901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The relationship between catechol O-methyltransferase and diseases].
    Qian XK; Xia YL; Dou TY; Hou J; Ma H; Ge GB; Yang L; Bi XL
    Yao Xue Xue Bao; 2016 Apr; 51(4):543-51. PubMed ID: 29859522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia--relationship with COMT Val¹⁰⁸/¹⁵⁸Met polymorphism, gender and symptomatology.
    Boot E; Booij J; Abeling N; Meijer J; da Silva Alves F; Zinkstok J; Baas F; Linszen D; van Amelsvoort T
    J Psychopharmacol; 2011 Jul; 25(7):888-95. PubMed ID: 21447540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic drugs and erythrocyte catechol-O-methyltransferase in schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Biol Psychiatry; 1982 Nov; 17(11):1339-42. PubMed ID: 6129906
    [No Abstract]   [Full Text] [Related]  

  • 35. Distribution, properties, and inhibitor sensitivity of zebrafish catechol-O-methyl transferases (COMT).
    Semenova S; Rozov S; Panula P
    Biochem Pharmacol; 2017 Dec; 145():147-157. PubMed ID: 28844929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and derivatives as potent and long-acting peripheral inhibitors of catechol-O-methyltransferase.
    Learmonth DA; Vieira-Coelho MA; Benes J; Alves PC; Borges N; Freitas AP; da-Silva PS
    J Med Chem; 2002 Jan; 45(3):685-95. PubMed ID: 11806720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of human catechol-O-methyltransferase-mediated dopamine O-methylation by daphnetin and its Phase II metabolites.
    Liang SC; Ge GB; Xia YL; Pei-Pei D; Ping W; Qi XY; Cai-Xia T; Ling Y
    Xenobiotica; 2017 Jun; 47(6):498-504. PubMed ID: 27435571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of catechol O-methyl-transferase (COMT) and properties of selective COMT inhibitors.
    Männistö PT; Ulmanen I; Lundström K; Taskinen J; Tenhunen J; Tilgmann C; Kaakkola S
    Prog Drug Res; 1992; 39():291-350. PubMed ID: 1475365
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of catechol O-methyltransferase val(158)met polymorphism on the p50 gating endophenotype in schizophrenia.
    Lu BY; Martin KE; Edgar JC; Smith AK; Lewis SF; Escamilla MA; Miller GA; Cañive JM
    Biol Psychiatry; 2007 Oct; 62(7):822-5. PubMed ID: 17448448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia.
    Woodward ND; Jayathilake K; Meltzer HY
    Schizophr Res; 2007 Feb; 90(1-3):86-96. PubMed ID: 17123785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.